Parssanedjad completed medical studies at the University of Essen, Germany, at Harvard University, Boston, US and at St. Johns Medical College, Bangalore, India and holds a doctor degree for his molecular biological work in the field of gene therapy. Prior to joining TVM Capital, he worked as an engagement manager for McKinsey & Company, where he served pharmaceutical and private equity clients.